Nagibio
3 known investors
Nagi Bioscience provides automated in vivo testing using the C. elegans model to measure lifespan, healthspan, and biological age, offered as both an on-site platform (SydLab One) and contract research services. It serves biotech, nutraceutical, and pharmaceutical companies working on aging and longevity interventions.